A Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults and Adolescents With Uncontrolled Asthma

NCT02161757 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1207

Enrollment

INDUSTRY

Sponsor class

Conditions

Uncontrolled Asthma

Interventions

BIOLOGICAL: Tralokinumab
OTHER: Placebo

Sponsor

AstraZeneca